EMJ GOLD - European Medical Journal

This site is intended for healthcare professionals

Continue

Pharma News, Views & Analysis

Filter Advertise With Us
White House

Trump administration cuts more than 90% of USAID funding

The Trump administration is set to cut a total of $60bn in US assistance worldwide, signalling a major shift in health policy.

Eli Lilly plans record $50bn US manufacturing investment

The company’s investment will expand its US manufacturing footprint and is the largest investment of its kind in history.
The world

EMA grants accelerated review to Gilead’s PrEP drug

The EMA is set to perform accelerated reviews of Gilead Sciences’ applications for its twice-yearly injectable for HIV prevention.
Handshake on a green background

AstraZeneca pays $160m for FibroGen's China subsidary

FibroGen, Inc. has announced the sale of its Chinese subsidiary to AstraZeneca, including the rights to roxadustat in China.

FDA fast-tracks Boehringer's NSCLC drug review

The FDA has granted priority review to zongertinib for non-small cell lung cancer (NSCLC).
Data

ABPI urges NHS to improve data access for pharma research

A new cross-industry report is calling for the UK’s NHS to design its health data infrastructure to meet the needs of pharma researchers.

FDA approves first at-home coeliac genetic test

A new at-home genetic test that assesses the risk of developing coeliac disease has received approval from US regulators.

Kennedy secures US health role despite backlash

Robert F. Kennedy Jr has been confirmed as the US Secretary of Health and Human Services following a 52-48 Senate vote.
We’ve noticed you’re accessing
from North/South America.